APA (7th ed.) Citation

C, L., M, D., D, V., L, B., B, G., E, G., . . . O, A. (2019). Distinct prognostic value of circulating anti-telomerase CD4+ Th1 immunity and exhausted PD-1+/TIM-3+ T cells in lung cancer. British journal of cancer, 121(5), 405. https://doi.org/10.1038/s41416-019-0531-5

Chicago Style (17th ed.) Citation

C, Laheurte, et al. "Distinct Prognostic Value of Circulating Anti-telomerase CD4+ Th1 Immunity and Exhausted PD-1+/TIM-3+ T Cells in Lung Cancer." British Journal of Cancer 121, no. 5 (2019): 405. https://doi.org/10.1038/s41416-019-0531-5.

MLA (9th ed.) Citation

C, Laheurte, et al. "Distinct Prognostic Value of Circulating Anti-telomerase CD4+ Th1 Immunity and Exhausted PD-1+/TIM-3+ T Cells in Lung Cancer." British Journal of Cancer, vol. 121, no. 5, 2019, p. 405, https://doi.org/10.1038/s41416-019-0531-5.